Cantor Fitzgerald reaffirmed their buy rating on shares of Omega Healthcare Investors (NYSE:OHI) in a research note released on Tuesday morning. Cantor Fitzgerald currently has a $34.00 price objective on the real estate investment trust’s stock.
“Revising 2018 estimates. We are reducing our 2018 revenue estimate to $910 million from $943 million to reflect OHI’s fourth-quarter asset sales, assets held for sale, and an additional $300 million of potential asset dispositions in 2018. We are reducing our 2018 FFO estimate to $2.95 from $3.11 and reducing our 2018 AFFO estimate to $3.03 from $3.26. That said, we will revisit our estimates after the Feb. 14 morning earnings call.”,” Cantor Fitzgerald’s analyst wrote.
Several other research analysts also recently weighed in on the stock. Zacks Investment Research downgraded shares of Omega Healthcare Investors from a buy rating to a hold rating in a research report on Friday, November 3rd. Hilliard Lyons downgraded shares of Omega Healthcare Investors to a buy rating in a research report on Wednesday, November 1st. Vetr downgraded shares of Omega Healthcare Investors from a buy rating to a hold rating and set a $32.96 price objective on the stock. in a research report on Monday, October 30th. Stifel Nicolaus downgraded shares of Omega Healthcare Investors from a buy rating to a hold rating and decreased their price objective for the company from $35.00 to $29.00 in a research report on Tuesday, October 31st. Finally, SunTrust Banks set a $28.00 price objective on shares of Omega Healthcare Investors and gave the company a hold rating in a research report on Monday, January 22nd. Three equities research analysts have rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company. The stock presently has a consensus rating of Hold and a consensus price target of $31.37.
Omega Healthcare Investors (NYSE OHI) opened at $26.74 on Tuesday. The company has a debt-to-equity ratio of 1.18, a current ratio of 3.55 and a quick ratio of 3.40. Omega Healthcare Investors has a 52-week low of $24.90 and a 52-week high of $35.14. The firm has a market cap of $5,270.00, a P/E ratio of 58.13, a price-to-earnings-growth ratio of 2.71 and a beta of 0.41.
Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Tuesday, February 13th. The real estate investment trust reported $0.31 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.49 by ($0.18). Omega Healthcare Investors had a return on equity of 2.48% and a net margin of 11.06%. The business had revenue of $221.21 million during the quarter, compared to the consensus estimate of $219.07 million. sell-side analysts predict that Omega Healthcare Investors will post 3.18 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, February 15th. Stockholders of record on Wednesday, January 31st were given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 9.87%. This is an increase from Omega Healthcare Investors’s previous quarterly dividend of $0.65. The ex-dividend date of this dividend was Tuesday, January 30th. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 573.91%.
In other news, Director Bernard J. Korman acquired 100,000 shares of the firm’s stock in a transaction dated Friday, December 22nd. The shares were purchased at an average cost of $26.89 per share, for a total transaction of $2,689,000.00. Following the transaction, the director now directly owns 896,895 shares of the company’s stock, valued at $24,117,506.55. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.54% of the stock is owned by company insiders.
Several hedge funds have recently made changes to their positions in OHI. Barnett & Company Inc. grew its stake in Omega Healthcare Investors by 1,980.0% during the third quarter. Barnett & Company Inc. now owns 5,200 shares of the real estate investment trust’s stock valued at $166,000 after acquiring an additional 4,950 shares in the last quarter. Mcmillion Capital Management Inc. purchased a new position in Omega Healthcare Investors during the third quarter valued at $201,000. Timber Hill LLC purchased a new position in Omega Healthcare Investors during the third quarter valued at $206,000. Good Life Advisors LLC purchased a new position in Omega Healthcare Investors during the third quarter valued at $209,000. Finally, Cetera Investment Advisers purchased a new position in Omega Healthcare Investors during the second quarter valued at $235,000. Hedge funds and other institutional investors own 67.90% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This story was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.dispatchtribunal.com/2018/02/17/cantor-fitzgerald-reaffirms-buy-rating-for-omega-healthcare-investors-ohi.html.
Omega Healthcare Investors Company Profile
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.